ALEXANDRIA, Va., March 17 -- United States Patent no. 12,577,609, issued on March 17, was assigned to The Rockefeller University (New York).

"Methods for cell-type specific profiling to identify drug targets" was invented by Nathaniel Heintz (New York) and Xiao Xu (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides methods of profiling gene and protein expression of a plurality of nuclei from a single cell type and comparing the profiles to determine variability among cell populations, samples from different subjects, and cells expressing a disease phenotype."

The patent was filed on Feb. 9, 2018, under Application No. 16/485,043.

*For further information, including imag...